期刊文献+

2型糖尿病患者血清甲状腺激素水平变化的临床意义 被引量:9

Clinical significance of serum thyroid hormones in patients with type 2 diabetes
下载PDF
导出
摘要 目的观察2型糖尿病患者血清甲状腺激素水平的改变。方法将168例2型糖尿病患者按糖化血红蛋白(GHbA1c)高低分四组:<6.5%组,6.5%-7.5%组,7.6%-10.0%组,>10.0%组;按是否有血管并发症分为:无并发症组,伴大血管并发症组,伴微血管并发症组及伴大、微血管并发症组。检测甲状腺激素水平。结果与正常对照组比较,2型糖尿病组TT3、FT3明显下降(P<0.01);与GHbA1c<6.5%组比较,6.5%-7.5%组(P<0.05)、7.6%-10.0%组(P<0.01)、>10.0%组TT3、FT3均明显下降(P<0.01)。与无并发症组比较,伴大血管组、微血管组及伴大微血管组TT3、FT3均明显下降(P<0.01)。结论 2型糖尿病患者病情越重,甲状腺激素水平下降幅度越大。 Objective To observe the thyroid hormones in patients with type 2 diabetes.Methods One hundred and sixty-eight patients with type 2 diabetes were divided into four groups according to their glycosylated hemoglobin(GHbA1c) level(6.5%,6.5%-7.5%,7.6%-10.0%,10.0%).The patients were further divided into no complication group,major vascular complication group,microvascular complication group,and major and microvascular complication group.Thyroid hormone levels were measured in all patients.Results The level of TT3 and FT3 was lower in patients with type 2 diabetes than in control group(P0.01).The level of TT3 and FT3 was higher in 6.5%-7.5% and 7.6%-10.0% GHbA1c groups,and lower in 10.0% GHbA1c group than in GHbA1c6.5% group(P0.01).The level of TT3 and FT3 was significantly lower in patients with complications than in those without complications.Conclusion The severer the type 2 diabetes is,the lower the thyroid hormone level is.
出处 《军医进修学院学报》 CAS 2011年第1期32-33,51,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 糖尿病 2型 甲状腺素 甲状腺功能减退症 Diabetes Mellitus Type 2 Thyroxine Hypothyroidism
  • 相关文献

参考文献5

二级参考文献11

共引文献24

同被引文献77

  • 1谢锦桃,刘军,周盛鹏,朱素君,冷爱文.美国糖尿病协会2009糖尿病诊疗指南解读[J].中国全科医学,2009,12(14):1255-1257. 被引量:82
  • 2Andrea Tura, et al. Basal and dynamic proinsulin - insulin relationship to assessβcell function during OGTT in metabolic disorders, Am J Physiol Endocrinol Metab 2003 ;285 : 155 - 162.
  • 3Beth Elaine Dunning and John E. Gerich, The Role ofαCell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications Endocrine Reviews 2007;28 (3) :253 -283.
  • 4Xin Y, Yang M, Chen X J, et al. Clinical features at the onset of child- hood type 1 diabetes mellitus in Shenyang, China[ J]. J Paediatr Child Health,2010,46(4) : 171 - 175.
  • 5Daneman D. State of the world's children with diabetes[ J]. Pediatr Dia- betes,2009,10(2) :120 - 126.
  • 6Economidou F, Douka E,Tzanela M,et al. Thyroid function during criti- cal illness [ J ]. Int J Endocrinol Metabol,2011,10 (2) : 117 - 124.
  • 7Bello G, Ceaichisciuc I, Silva S,et al. The role of thyroid dysfunction in the critically ill : A review of the literature [ J ]. Minerva Anestesiol,2010, 76( 11 ) :919 -928.
  • 8Pappa TA, Vagenakis AG, Alevizaki M. The nonthyroidal illness syn- drome in the non - critically ill patient[ J]. Eur J Clin Invest ,2011,41 (2) :212 -220.
  • 9Meyer S, Schuetz P, Wieland M, et al. Low triiodothyronine syndrome : A prognostic marker for outcome in sepsis[ J] ? Endocr/ne,2011,39(2) : 167 - 174.
  • 10Sicree RA, Zimmet PZ, Dunstan DW, et al. Differences in height ex- plain gender differences in the response to the oral glucose tolerance test the AusDiab study[J]. Diabet Med,2008,25(3) :296 -302.

引证文献9

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部